Education
About Us
Working with TipRanks
Follow Us
Nufarm Limited (AU:NUF)
ASX:NUF
Top Page
Nufarm Limited
(Sydney:NUF)
63Neutral
Nufarm Limited (NUF) vs. S&P 500 (SPY)
Market Cap
$1.56B
Dividend Yield2.21%
Average Volume (3M)896.18K
Price to Earnings (P/E)―
Beta (1Y)0.92
Revenue Growth-3.87%
EPS Growth-125.79%
CountryAU
Employees3,159
SectorBasic Materials
Sector Strength60
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)-0.08
Shares Outstanding382,983,100
10 Day Avg. Volume1,155,508
30 Day Avg. Volume896,184
Financial Highlights & Ratios
PEG Ratio-2.26
Price to Book (P/B)0.82
Price to Sales (P/S)0.00
P/FCF Ratio45.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$4.50Price Target Upside10.64% Upside
Rating ConsensusHold
Number of Analyst Covering3
Nufarm Limited Business Overview & Revenue Model
Company DescriptionNufarm Limited, together with its subsidiaries, develops, manufactures, and sells crop protection solutions and seed technologies in Europe, the Middle East, Africa, North America, and the Asia Pacific. It operates through two segments, Crop Protection and Seed Technology. The company's protection solutions include herbicides, insecticides, and fungicides that help growers protect crops against weeds, pests, and diseases. It focuses on crops, such as cereals; corn; soybean; pasture, turf, and ornamentals; and trees, nuts, vines, and vegetables. It also provides seed treatment products for the protection and treatment of damage caused by insects, fungus, and disease; and distributes sunflower, sorghum, and canola seeds. Nufarm Limited was founded in 1916 and is headquartered in Laverton North, Australia.
How the Company Makes MoneyNufarm Limited generates revenue primarily through the sale of its crop protection products, which include herbicides, insecticides, and fungicides. These products are essential for farmers to increase crop yields by managing weeds, pests, and plant diseases. The company benefits from a broad portfolio of active ingredients and proprietary formulations, catering to various crops and climatic conditions across the globe. Nufarm's revenue streams are further supported by strategic partnerships and distribution agreements that enhance its market reach and product availability. Additionally, the company invests in research and development to innovate and expand its product offerings, ensuring competitiveness in the agricultural chemicals industry.
Nufarm Limited Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | |||||
| TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 4.05B | 3.35B | 3.48B | 3.77B | 3.22B | 2.85B | Gross Profit |
| 1.10B | 840.37M | 1.03B | 972.59M | 834.71M | 734.73M | EBIT |
| 117.61M | 0.00 | 239.40M | 203.16M | 151.17M | -428.54M | EBITDA |
| 305.76M | 263.77M | 427.18M | 421.60M | 363.37M | -69.59M | Net Income Common Stockholders |
| -15.97M | -5.60M | 111.14M | 107.44M | 65.13M | -456.08M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 460.73M | 463.56M | 410.96M | 585.70M | 724.22M | 686.55M | Total Assets |
| 4.64B | 4.43B | 4.63B | 4.66B | 4.37B | 4.54B | Total Debt |
| 954.30M | 1.10B | 1.26B | 931.87M | 1.04B | 1.13B | Net Debt |
| 493.58M | 634.76M | 849.84M | 346.17M | 316.82M | 441.26M | Total Liabilities |
| 2.51B | 2.22B | 2.32B | 2.51B | 2.25B | 2.39B | Stockholders Equity |
| 2.12B | 2.21B | 2.31B | 2.15B | 2.12B | 2.14B |
| Cash Flow | Free Cash Flow | ||||
| 208.53M | 219.43M | -352.36M | 160.20M | 281.70M | -400.42M | Operating Cash Flow |
| 442.18M | 0.00 | -125.62M | 321.12M | 424.19M | -231.51M | Investing Cash Flow |
| -370.14M | -207.46M | -241.73M | -240.41M | -146.30M | 1.12B | Financing Cash Flow |
| -167.36M | -200.76M | 185.98M | -264.37M | 19.18M | -670.68M |
Nufarm Limited Technical Analysis
Positive
4.07
Price Trends
3.87
Positive
3.77
Positive
3.84
Positive
Market Momentum
0.05
Negative
62.03
Neutral
78.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NUF, the sentiment is Positive. The current price of 4.07 is above the 20-day moving average (MA) of 3.88, above the 50-day MA of 3.87, and above the 200-day MA of 3.84, indicating a bullish trend. The MACD of 0.05 indicates Negative momentum. The RSI at 62.03 is Neutral, neither overbought nor oversold. The STOCH value of 78.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:NUF.
Nufarm Limited Peers Comparison
Overall Rating
UnderperformOutperform
Sector (50)
Financial Indicators
Performance Comparison
AU:NUF
Nufarm Limited
4.07
-1.04
-20.41%
SHVTF
Select Harvests
3.35
1.19
55.09%
ICPVF
Incitec Pivot
1.72
-0.20
-10.42%
ASAGF
Australian Agricultural Company
1.00
0.06
6.38%
GRCLF
Graincorp Limited Class A
4.57
-1.03
-18.39%
NNCSF
Nanosonics Limited
3.08
1.18
62.11%
Nufarm Limited Earnings Call Summary
Earnings Call Date:Nov 13, 2024
(Q4-2024)
| % Change Since: 11.20%|
Next Earnings Date:May 21, 2025
Earnings Call Sentiment Neutral
The earnings call reflects a challenging year with significant revenue and profit declines, particularly in North America and Europe. However, the company achieved notable successes in networking capital reduction, omega-3 sales, and new product introductions. While there are clear strategies for cost reduction and growth, the financial metrics and market conditions indicate a mixed outlook.Q4-2024 Updates
Positive Updates
Outstanding Networking Capital Reduction
Nufarm achieved an outstanding result on networking capital with a 30% reduction on the prior year, significantly reducing debt.
Net Debt Reduction
The company ended the year with net debt of $635 million, which was 25% below the prior year.
Successful Product Launches
New product introductions contributed to more than 15% of revenues, including the successful launch of Oxbow Herbicide in Canada.
Omega-3 Target Achievement
Nufarm reached its target of $50 million in omega-3 sales and expanded its grower base and planted area.
APAC Segment Performance
The APAC segment reported EBITDA of $88 million, in line with the prior year, with exceptional results in Asia.
Negative Updates
Decline in North America Earnings
Underlying EBITDA in North America was 49% below the prior year due to price competition impacting margins.
European Segment Challenges
Underlying EBITDA in Europe was 25% below the prior year, with pricing pressure on foundational products and lower sales volumes.
Overall Revenue Decline
Revenue was 4% below the prior year, with underlying EBITDA 29% below prior year, and underlying EBIT 57% below prior year.
Negative Earnings Per Share
The company reported an underlying basic earnings per share of negative $0.063.
Seed Technologies EBITDA Decline
EBITDA in seed technologies was 15% below the prior year, with lower licensing revenue and higher costs as a contributing factor.
Company Guidance
During the Nufarm Limited FY '24 Results Call, CEO Greg Hunt provided a detailed overview of the company's performance and strategic direction. Despite industry challenges, Nufarm achieved an EBITDA at the midpoint of the revised guidance given on August 15, 2024. The company reported a 30% reduction in net working capital, which helped reduce net debt by 25% to $635 million, achieving a net leverage of 2x EBITDA. However, due to reduced earnings, there will be no final dividend for FY '24. Nufarm launched new products, with more than 15% of revenues derived from these introductions, and achieved $50 million in omega-3 sales. The company is targeting $50 million in annualized savings in overhead costs and a 25-day reduction in inventory by FY '25. Despite a 4% revenue decline and a $6 billion statutory net profit loss, Nufarm remains focused on cost management and growth, with plans to scale omega-3 and biofuels operations.Nufarm Limited Corporate Events
Nufarm Limited Announces Change in Substantial Holder Interests
May 12, 2025
Nufarm Limited has announced a change in the interests of its substantial holder, L1 Capital Pty Ltd, which affects the voting power associated with its shares. This change in relevant interests could have implications for the company’s governance and decision-making processes, potentially impacting stakeholders and the company’s strategic direction.
Nufarm Limited to Announce 2025 Half-Year Financial Results
May 2, 2025
Nufarm Limited will announce its 2025 half-year financial results on May 21, 2025, with a briefing for investors scheduled on the same day. This announcement is significant for stakeholders as it provides insights into the company’s financial health and strategic direction, potentially impacting its market positioning and investor relations.
Nufarm Director Increases Stake Significantly
Mar 17, 2025
Nufarm Limited announced a change in the director’s interest, with Alexandra Gartmann acquiring 12,850 additional securities through an on-market trade, bringing her total to 31,300 shares. This change reflects a significant increase in Gartmann’s stake in the company, potentially indicating confidence in Nufarm’s future performance and aligning her interests more closely with those of the shareholders.
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.